We examined the effect of dose and transport inhibitors on the pharmacokinetics of phenol red as a model drug after application to rat liver surface in-vivo, employing a cylindrical glass cell (i.d. 9 mm, area 0.64 cm2), to elucidate the mechanism for drug absorption from liver surface membrane.
Introduction
Liver site-specific drug delivery is of interest since normal treatment of liver diseases by intravenous and oral administration route has been frustrated by inadequate delivery into liver as well as toxicity in other organs. The direct way such as drug application to liver surface is supposed to be a useful method for drug delivery to the target site in liver.
In our previous paper (Nishida et al 1994) , we selected organic anions (phenol red, bromphenol blue and bromosulphonphthalein) as model drugs and examined their in-vivo behaviour after application to rat liver surface. Absorption ratios in 6 h of model drugs were relatively large (> 59 %) and significant prolongation of blood concentration was observed. For therapeutic application to liver disease, further work is required to elucidate the mechanism for drug absorption from liver surface membrane.
The main purpose of present study is to obtain the information concerning the absorption mechanism from liver surface membrane. We selected phenol red as a model drug, of which absorption ratio was the largest among three organic anions. First, we analyzed pharmacokinetically the dose dependency in phenol red absorption. Next, we examined the effect of established transport inhibitors of metabolic energy and anion transport on the pharmacokinetics of phenol red after application to rat liver surface.
Materials and Methods

Chemicals
Phenol red and 2,4-dinitrophenol were purchased from Nacalai Tesque, Inc., Kyoto, Japan.
Probenecid was obtained from Wako Pure Chemical Industries, Ltd, Osaka, Japan. All other chemicals were of reagent grade.
In-vivo experiment
All animal experiments in the present study conformed to the Guideline for Animal Experimentation in Nagasaki University. Application to rat liver surface: A cylindrical glass cell (i.d. 9 mm, area 0.64 cm2) was attached to the rat liver surface at the area of the left lobe with Aron Alpha (Sankyo Co.
Ltd, Tokyo, Japan). The phenol red solution (0.3, 1 and 3 mg) was added to the glass cell directly.
In another experiment, transport inhibitor 2,4-dinitrophenol (0.3 mg) or probenecid (0.5 or 1 mg) was added into the glass cell simultaneously.
Intravenous administration: The phenol red solution (0.3, 1 and 3 mg) was injected into the jugular vein.
Blood samples (200 mL) were collected at selected times after dosing from the heparinized cannula inserted into femoral artery over 6 h period and centrifuged at 15000 rpm for 5 min. Bile samples were collected at appropriate time intervals for 6 h. At 6 h after the application, urine was collected from the bladder directly by syringe. Following application to rat liver surface, phenol red solution remaining in the glass cell was withdrawn at 6 h after dosing.
To study the time course of remaining amount of phenol red in plasma and glass cell, and cumulative amount of total phenol red excreted in bile and urine, certain experiments were carried out up to 0.5, 1, 2 and 4 h at a dose of 0.3 mg. The concentrations of free phenol red in plasma, bile, urine and remaining solution in glass cell were determined spectrophotometrically at 560 nm after dilution with a 1 M NaOH solution.
The total concentration of free phenol red and its metabolite was measured in the same manner after they were subjected to acid hydrolysis (1 M HCl at 100｡C for 30 min) (Hart & Schanker 1966) . The concentration of phenol red metabolite was estimated from the difference between these values.
Calculation of moment parameters
The plasma concentration profiles and biliary excretion rate-time curves of free phenol red and its metabolite were analyzed based on statistical moment theory. Moment parameters for plasma concentration profile of free phenol red (AUCp, MRTp) and those for biliary excretion rate-time curves of free phenol red (AUCb,f, MRTb,f) and its metabolite (AUCb,m, MRTb,m) were calculated using a linear trapezoidal formula and extrapolation to infinite time based on a monoexponential equation (Yamaoka et al 1978) .
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Compartment model analysis
First, the plasma concentration (Cp) profiles of phenol red at a dose of 0.3, 1 and 3 mg after intravenous administration into rat was fitted to the biexponential equation described as follows, by the nonlinear least-squares method (Yamaoka et al 1981) .
<equation> Hybrid parameters a and b are defined as a + b = K12 + K21 + Kel and . Vc is the volume of the central compartment.
Kel is the first-order elimination rate constant from the central compartment. K12 and K21 are the first-order transfer rate constants between the central and peripheral compartment. These parameters were substituted into the following equation for plasma concentration in the application of phenol red to rat liver surface. Next, in the same way, the plasma concentration profile of phenol red after application to rat liver surface was fitted in the two-compartment model with first-order absorption, by the nonlinear least-squares method (Yamaoka et al 1981) .
In this model, the equation for plasma concentration of phenol red is given by the following equation.
<equation> Ka is the first-order absorption rate constant for phenol red absorption into the blood stream from rat liver surface. F is the availability of phenol red after application to rat liver surface. Figure 1 shows the plasma concentration profiles of phenol red after application to rat liver surface at a dose of 0.3, 1 and 3 mg. At every dose, plasma concentration of phenol red reached a maximum at 1 or 1.5 h after dosing, followed by gradual disappearance. Table 1 . Absorption ratios of phenol red in 6 h calculated from the remaining amount of phenol red in glass cell were 91.1, 91.8 and 89.9 % at a dose of 0.3, 1 and 3 mg, respectively, indicating that the phenol red absorption from rat liver surface membrane shows no saturation within the dose range used. Biliary and urinary recovery ratio of phenol red metabolite decreased significantly at a dose of 3 mg, suggesting the saturation of metabolic process of phenol red at the highest dose. Similar trend was seen in intravenous administration of phenol red into rats (data not shown).
Results and Discussion
Dose dependency
Moment parameters for plasma concentration profile of free phenol red and biliary excretion rate-time curves of free phenol red and its metabolite are listed in Table 2 . No significant difference was seen in AUCp/dose value among three doses, suggesting the linearity of phenol red absorption from rat liver surface membrane. As expected from the patterns in Figs 1 and 2 , MRTp, MRTb,f and MRTb,m values were almost same among three doses.
Time course of phenol red distribution in plasma, bile, urine and glass cell
To assess the absorption characteristics from rat liver surface membrane, we studied the time course of phenol red distribution in plasma, bile, urine and glass cell after application to rat liver surface at a dose of 0.3 mg (Fig. 3) .
Remaining amount of phenol red in plasma determined by Cp X Vplasma (plasma volume in rat) was plotted against time in Fig. 3 , where
Vplasma was estimated from the previous paper (Bischoff et al 1971) . A relatively small amount of phenol red (< 7.2 %) was detected in plasma. Cumulative amount of total phenol red (free phenol red and its metabolite) excreted in bile and urine reached a plateau level at 4 h after dosing and exhibited a similar pattern. Therefore, there is no significant difference in urinary and biliary excretion process of phenol red with respect to rate.
< Fig. 3 >
On the other hand, remaining amount of phenol red in glass cell declined rapidly. A semi-log plot of the remaining amount of phenol red in glass cell gave a straight line (correlation coefficient: 0.99) as shown in Fig. 4 , indicating that the phenol red absorption from rat liver surface proceeds via first-order. Its rate constant Ka was calculated to be 0.0069 min-1. Also, this result supports the employment of two-compartment model incorporating first-order absorption to describe the plasma concentration profile of phenol red after application to rat liver surface.
< Fig. 4 >
Compartment Model Analysis
Pharmacokinetic parameters for phenol red after intravenous administration into rats are listed in Table 3 , and used in the following analysis. The plasma concentration profile of phenol red after application to rat liver surface was fitted in the two-compartment model with first-order absorption. Ka and F obtained by curve fitting are given in Table 3 . Figure 1 shows the simulation curves for plasma concentration of phenol red after application to rat liver surface at a dose of 0.3, 1 and 3 mg, which had been reconstructed employing the estimated parameters shown in Table 3 . In general, a good agreement was observed between fitted lines and experimentally observed data at every dose. The obtained Ka correlated closely with the value determined by elimination profile of phenol red from glass cell (Fig. 4) , suggesting the validity of this pharmacokinetic model. No significant difference was seen in Ka value at a dose of 0.3, 1 and 3 mg (Table 3) . Accordingly, linearity of phenol red absorption from rat liver surface membrane was confirmed.
Effect of transport inhibitors
From these results, it is suggested that phenol red absorption from rat liver surface membrane might be explained mostly by passive diffusion. The saturative specialized absorption process of phenol red in rat lung is known to be inhibited by metabolic inhibitors and structurally related organic anions (Enna & Schanker 1973; Gardiner & Schanker 1976 ).
Thus, we examined the effect of metabolic inhibitor 2,4-dinitrophenol, which blocks oxidative phosphorylation, on the phenol red absorption to determine whether phenol red absorption depends on metabolic energy. Next, we studied the influence of structurally related organic anion probenecid on the phenol red absorption, to know the structural specificity in the absorption system of phenol red.
Biliary and urinary recovery (% of dose) of free phenol red and its metabolite at a dose of 0.3 mg in the presence of 2,4-dinitrophenol (0.3 mg) and probenecid (0.5 and 1 mg) did not change compared to control, as shown in Table 4 . Absorption ratios of phenol red in 6 h after application to rat liver surface ranged from 89.2 to 94.5 % in the presence of transport inhibitors. 2,4-Dinitrophenol and probenecid as transport inhibitors did not cause a reduction of the phenol red absorption from rat liver surface.
The plasma concentration profiles of phenol red after application to rat liver surface in the presence of transport inhibitors was almost same as that of control (data not shown).
Similar trend was seen in the biliary excretion rate-time curves of free phenol red and its metabolite after application to rat liver surface (data not shown).
Moment parameters for phenol red after application to rat liver surface in the presence of transport inhibitors are given in Table 5 , which were of the same magnitude as that of control. Accordingly, it is concluded that transport inhibitor 2,4-dinitrophenol and probenecid had no significant effect on the phenol red absorption from rat liver surface membrane.
Consequently, it is suggested that specialized transport process such as active transport might not exist in the phenol red absorption from rat liver surface membrane. Thus, a simple passive diffusion system is considered to play an important role in the phenol red absorption from liver surface. In future, several factors influencing the drug absorption from liver surface should be clarified for practical use.
